Mechanistic comparison of Cefixime and Dithiazanine 3-Ethyl-2-(5-(3-ethyl-2-benzothiazolinylidene)-1 based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
4
Shared Targets
13%
Jaccard Similarity
13%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Cefixime and Dithiazanine share 4 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.133 means 13% of the combined target set is bound by both compounds. The IDF-weighted score of 0.128 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Cefixime and Dithiazanine have in common?
Cefixime and Dithiazanine share 4 molecular targets with a Jaccard similarity of 13%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Cefixime and Dithiazanine be combined?
Cefixime and Dithiazanine share 4 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Cefixime or Dithiazanine?
Both Cefixime and Dithiazanine have substantial PubMed research. View their individual profiles for full evidence scores.